<SEC-DOCUMENT>0001185185-26-000269-index.html : 20260126
<SEC-HEADER>0001185185-26-000269.hdr.sgml : 20260126
<ACCEPTANCE-DATETIME>20260126063014
ACCESSION NUMBER:		0001185185-26-000269
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20260126
FILED AS OF DATE:		20260126
DATE AS OF CHANGE:		20260126

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anbio Biotechnology
		CENTRAL INDEX KEY:			0001982708
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42526
		FILM NUMBER:		26558374

	BUSINESS ADDRESS:	
		STREET 1:		FRIEDRICH-EBERT-ANLAGE 49
		CITY:			FRANKFURT AM MAIN
		STATE:			2M
		ZIP:			60308
		BUSINESS PHONE:		4916096247281

	MAIL ADDRESS:	
		STREET 1:		FRIEDRICH-EBERT-ANLAGE 49
		CITY:			FRANKFURT AM MAIN
		STATE:			2M
		ZIP:			60308
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>anbio6k012526.htm
<DESCRIPTION>FORM 6-K
<TEXT>
Document 1 - file: anbio6k012526.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>anbioex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
Document 2 - file: anbioex10-1.htm

</DOCUMENT>
</SEC-DOCUMENT>